Updating results

2 results for ta20

Sort: Relevance | Date

Guidance on the use of Riluzole (Rilutek) for the treatment of Motor Neurone Disease (TA20)

Evidence-based recommendations on the use of Riluzole (Rilutek) for treating motor neurone disease (MND)

Technology appraisal guidance Published January 2001

Static list

NICE technology appraisal guidance static list

Published January 2018 Last updated January 2018